Company intelligence / Profile preview

Saudia

Jeddah, Makkah, Saudi Arabia

Ownership: Private
Development stage: Other

Overview

SaudiVax is a biopharmaceutical company based in Saudi Arabia focused on developing and manufacturing vaccines and therapeutic antibodies for infectious diseases prevalent in the Middle East. The company operates as a joint venture between UYC and PnuVax, aiming to establish the first world-class biomanufacturing facility in the region that adheres to Halal standards. Its primary focus includes addressing regional health threats such as MERS-CoV and COVID-19 through localized production of biologics. SaudiVax leverages strategic partnerships with academic and international organizations to build a sustainable biotechnology ecosystem in the Kingdom.

Therapeutic areas: Infectious Diseases
Modalities: VaccineMonoclonal antibodyBiologic
Industry: Biotech

Partnerships

PnuVaxUYCSartoriusMerck KGaA

Beyond the preview

Go deeper on Saudia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Saudia.

Explore the full profile